Bacteria seen as potential lupus triggers

FROM SCIENCE TRANSLATIONAL MEDICINE A new study points to bacteria commonly found in the ...

FDA approves IL-23 antagonist for plaque psoriasis

The Food and Drug Administration has approved tildrakizumab, an interleukin-23 antagonist, for the treatment ...

Allopurinol dose not escalated enough to reduce mortality

FROM ARTHRITIS & RHEUMATOLOGY An allopurinol dose escalation strategy for patients with gout was ...

Arthritis limits physical activity the most in the South

FROM MMWR SURVEILLANCE SUMMARIES “Physical activity is a proven strategy for managing arthritis symptoms,” ...

Ultrasound study supports deep Koebner mechanism in PsA pathology

FROM ANNALS OF THE RHEUMATIC DISEASES An ultrasonographic study describing the greater presence of ...

Intramuscular steroid injection reduced hip OA pain up to 12 weeks

FROM ANNALS OF THE RHEUMATIC DISEASES Systemic treatment with an intramuscular glucocorticoid injection is ...